Showing results (1671-1680 of 1,994) with videos related to

Sort By:
Pageof 200
HGG Advances|August 26, 2024
Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventionsLillian Phung, Elisabeth Wood, Brian Egleston, et al.
JCO Clinical Cancer Informatics|August 28, 2023
Development of an Electronic Health Record-Based Clinical Decision Support Tool for Patients With Lynch SyndromeKelsey S Lau-Min, Joseph Bleznuck, Colin Wollack, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Glutamatergic neuron-tumor synapses shape human glioblastoma cell states through radial glia plasticityAntoni Martija, Brianna N Bristow, Dakshesh Rana, et al.
JCO Precision Oncology|August 3, 2023
Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 CarriersDylane Wineland, Anh N Le, Ryan Hausler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2019
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast CancerAdam A Kraya, Kara N Maxwell, Bradley Wubbenhorst, et al.
American Journal of Human Genetics|March 1, 2003
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilityMieke Schutte, Sheila Seal, Rita Barfoot, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 17, 2004
Multicenter, prospective, double-blind, randomized trial of laparoscopic nissen vs anterior 90 degrees partial fundoplicationDavid I Watson, Glyn G Jamieson, Carolyn Lally, et al.
Neuro-Oncology|July 10, 2024
IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastomaAndrew J Hou, Ryan M Shih, Benjamin R Uy, et al.
Oncotarget|September 23, 2016
Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanomaClemens Krepler, Min Xiao, Minu Samanta, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed MelanomasVito W Rebecca, Min Xiao, Andrew Kossenkov, et al.
Pageof 200